Aggarwal BA, Kumar A, Aggarwal MS, Shishodia S. 2005. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In: Phytopharmaceuticals in Cancer Chemoprevention. CRC Press LLC, pp. 349–387
Aggarwal BB, Kumar A, Bharti AC. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res, 23:363–398
Aggarwal BB and Harikumar KB. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol, 41: 40–59
Ammon HP, Wahl MA. 1991. Pharmacology of Curcuma longa. Planta Med, 57:1–7
Ankola DD, Kumar. MNV. 2009. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci, 37:223-230
Anand P, Nair BH, Aggarwal BB. 2010. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. J Biochem, 79: 330-338
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. 2008. Curcumin and cancer: an “old-age” disease with an “age-old”. Solution, Cancer Lett, 267:133–164
Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. 2004. Turmeric and curcumin: biological actions and medicinal applications. Curr Sci, 87: 44–53
Chattopadhyay I, Biswas K, Bandyopadhyay U, Zhou RK, Beevers H, Huang S. 2011. The targets of curcumin. Curr Drug Targets, 12:332-347.
Dandekar PP, Patravale VB. 2009. Development and validation of a
stability-indicating LC method for curcumin. Chromatographia, 69:871-877
Jayaprakasha GK, Jena BS, Negi PS, Sakariah KK. 2002, Evaluation of antioxidant activities and antimutagenicity of turmeric oil: a byproduct from curcumin production, Z Naturforsch C, 57:828-835.
Kim HT, Jiang HH. 2011. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm, 403: 285-291
Koranya MA, Haggaga RS, Ragaba MA, Elmallahb OA. 2013. A validated stability-indicating HPLC method for simultaneous determination of Silymarin and Curcumin in various dosage forms. J Arab Chem, In press.
Rahimi HR, Mohammadpour AH, Dastani M, Jafari MR, AbnousK, Mobarhan MG, Kazemi Oskuee R. 2016. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed, 6: 567-577.
Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust Sh, Kazemi Oskuee R. 2016. Novel delivery for natural products: Nano-curcumin formulations. Avicenna J Phytomed, 6: 383-398.
Rouseff RL. 1988. High performance liquid chromatographic separation and spectral characterization of the pigments in turmeric and annatto. J Food Sci, 53:1823-1826
Tonnesen HH, Karlsen J. 1985. Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z. Lebensm. Unters. Forsch, 180: 402–404
Tonnesen HH, Karlsen J. 1985a. Studies of curcumin and curcuminoids. V. Alkaline degradation of curcumin. Z. Lebensm. Unters. Forsch, 180: 132-134
Tonnesen HH, Karlsen J, van Henegouwen GB. 1986. Studies on curcumin and curcuminoids. VIII. Photochemical stability of curcumin. Z Lebensm Unters Forsch, 183:116-122.
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed, 15:1867–1876
Wichitnithad W, Jongaroonngamsang N, Pummangura S, Rojsitthisak P. 2009. A simple isocratic HPLC method for the simultaneous determination of curcuminoids in commercial turmeric extracts. Phytochem Anal, 20:314-319.